Filters
Also try searching for:
*EVA
on 21 Apr 2020
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1879244 · 24 Jan 2018
005
Class 005
Pharmaceutical Products
Pharmaceutical products namely, analgesics, antipyretics, and antitussives.
Pharmaceutical products namely, analgesics, antipyretics, and antituss...
on 26 Jun 2020
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1879243 · 24 Jan 2018
005
Class 005
Pharmaceutical Products
Pharmaceutical products namely, analgesics.
Pharmaceutical products namely, analgesics.
on 21 Apr 2020
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1879246 · 24 Jan 2018
005
Class 005
Pharmaceutical Products
Pharmaceutical products namely, analgesics and sedatives.
Pharmaceutical products namely, analgesics and sedatives.
on 21 Apr 2020
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1879245 · 24 Jan 2018
005
Class 005
Pharmaceutical Products
Pharmaceutical products namely, analgesics and antipyretics.
Pharmaceutical products namely, analgesics and antipyretics.
on 14 Nov 2019
TEVA MEDICAL LTD.
1876344 · 08 Jan 2018
010
Class 010
Medical Instrument Products
Medical apparatus, namely, pharmaceutical vial adaptors, intravenous fluid bag adaptors, syringe adaptors, connectors for syringes and medical tubing, and parts and fittings therefor, for compounding and dispensing of pharmaceuticals to patients, namely, for introducing pharmaceutical preparations into the body of humans and animals.
Medical apparatus, namely, pharmaceutical vial adaptors, intravenous f...
on 20 Nov 2019
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1835940 · 04 May 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders, namely, Parkinson's disease and spinal muscular atrophy; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely, carpal tunnel syndrome and connective tissue diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely, dermatitis, eczema and psoriasis; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents for the treatment of the central nervous system, namely, for treating encephalitis, epilepsy, cerebral palsy, multiple sclerosis and Huntington's disease; Pharmaceutical agents for the treatment of circulatory systems, namely, for treating atherosclerosis, aneurysms and Raynaud's disease; Pharmaceutical agents affecting sensory organs, namely, for treating hearing loss and glaucoma; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases and incontinence.
Pharmaceutical preparations for the prevention and treatment of Alzhei...
on 20 Nov 2019
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1835942 · 04 May 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders, namely, Parkinson's disease and spinal muscular atrophy; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely, carpal tunnel syndrome and connective tissue diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely, dermatitis, eczema and psoriasis; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents for the treatment of the central nervous system, namely, for treating encephalitis, epilepsy, cerebral palsy, multiple sclerosis and Huntington's disease; Pharmaceutical agents for the treatment of circulatory systems, namely, for treating atherosclerosis, aneurysms and Raynaud's disease; Pharmaceutical agents affecting sensory organs, namely, for treating hearing loss and glaucoma; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases and incontinence.
Pharmaceutical preparations for the prevention and treatment of Alzhei...
on 20 Nov 2019
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1835947 · 04 May 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders, namely, Parkinson's disease and spinal muscular atrophy; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely, carpal tunnel syndrome and connective tissue diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely, dermatitis, eczema and psoriasis; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents for the treatment of the central nervous system, namely, for treating encephalitis, epilepsy, cerebral palsy, multiple sclerosis and Huntington's disease; Pharmaceutical agents for the treatment of circulatory systems, namely, for treating atherosclerosis, aneurysms and Raynaud's disease; Pharmaceutical agents affecting sensory organs, namely, for treating hearing loss and glaucoma; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases and incontinence.
Pharmaceutical preparations for the prevention and treatment of Alzhei...
on 20 Nov 2019
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1835949 · 04 May 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders, namely, Parkinson's disease and spinal muscular atrophy; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely, carpal tunnel syndrome and connective tissue diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely, dermatitis, eczema and psoriasis; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents for the treatment of the central nervous system, namely, for treating encephalitis, epilepsy, cerebral palsy, multiple sclerosis and Huntington's disease; Pharmaceutical agents for the treatment of circulatory systems, namely, for treating atherosclerosis, aneurysms and Raynaud's disease; Pharmaceutical agents affecting sensory organs, namely, for treating hearing loss and glaucoma; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases and incontinence.
Pharmaceutical preparations for the prevention and treatment of Alzhei...
on 20 Nov 2019
TEVA PHARMACEUTICAL INDUSTRIES LTD.
1835951 · 04 May 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders, namely, Parkinson's disease and spinal muscular atrophy; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely, carpal tunnel syndrome and connective tissue diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely, dermatitis, eczema and psoriasis; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents for the treatment of the central nervous system, namely, for treating encephalitis, epilepsy, cerebral palsy, multiple sclerosis and Huntington's disease; Pharmaceutical agents for the treatment of circulatory systems, namely, for treating atherosclerosis, aneurysms and Raynaud's disease; Pharmaceutical agents affecting sensory organs, namely, for treating hearing loss and glaucoma; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases and incontinence.
Pharmaceutical preparations for the prevention and treatment of Alzhe...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
Teva pharmaceutical industries ltd. (47)
Teva pharmaceutical industries ltd. a legal entity (5)
Deckers outdoor corporation (a delaware corporation) (2)
Tevano payment systems inc. a legal entity (2)
Adama studio llc (1)
Deckers outdoor corporation (1)
Pernod ricard mexico s.A. de c.V. (1)
Raffi khorchidian (1)
Teva medical ltd. (1)
Teva medical ltd. a legal entity (1)
Teva pharmaceutical industries ltd. a legal entity (1)
Teva pharmaceutical industries ltd. (1)
Categories
Class 5 (37)
Class 9 (18)
Class 10 (17)
Class 35 (16)
Class 44 (14)
Class 16 (13)
Class 41 (12)
Class 20 (9)
Class 1 (8)
Class 3 (7)
Class 42 (6)
Class 25 (3)
Class 7 (1)
Class 21 (1)
Class 33 (1)
Class 36 (1)
Correspondents
Osler, hoskin & harcourt llp (38)
Riches, mckenzie & herbert llp (11)
Aitken klee llp (5)
Perley-robertson, hill & mcdougall llp (2)
Kirby eades gale baker (1)
Lavery, de billy, llp (1)
Image Search
Drag and drop or upload to search any image